financetom
Business
financetom
/
Business
/
On Holding's Q4 Sales Miss a 'Major Disappointment' But Numbers Aren't Really 'Bad,' Wedbush Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
On Holding's Q4 Sales Miss a 'Major Disappointment' But Numbers Aren't Really 'Bad,' Wedbush Says
Mar 12, 2024 9:37 AM

12:27 PM EDT, 03/12/2024 (MT Newswires) -- On Holding's ( ONON ) lower-than-expected Q4 sales and 2024 sales guidance that is below expectations are likely to be viewed as a "major disappointment," but the numbers aren't bad in absolute terms, Wedbush said in a report Tuesday.

The company's Q4 net sales grew 22% from a year earlier, which Wedbush said is essentially in line with implied guidance.

"The stock was priced for a higher-growth scenario, so we understand the initial stock reaction," it said. "We don't think anything is 'wrong' here, and when the dust settles, we still think this is the strongest fundamental growth stories in our coverage."

On Holding ( ONON ) shares were down 14% in recent trading following the company's results, which also showed its Q4 swinging to a surprise loss.

"The biggest negative surprise in our view is the slowdown in the Americas, which only grew 29% constant-FX and 19% as-reported" in terms of revenue, Wedbush said. "Asia remained strong at +76% constant-FX, while Europe was +26% constant-FX."

Wedbush has an outperform rating on the stock with a price target of $38.

Price: 29.01, Change: -4.61, Percent Change: -13.71

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RenaissanceRe's DaVinciRe Prices $300 Million Private Debt Offering
RenaissanceRe's DaVinciRe Prices $300 Million Private Debt Offering
Feb 27, 2025
04:46 AM EST, 02/27/2025 (MT Newswires) -- RenaissanceRe Holdings ( RNR/PF ) said late Wednesday its DaVinciRe joint venture priced a $300 million private offering of 5.95% senior notes due 2035. The company expects the offering to close by March 5 and plans to use the net proceeds for general corporate purposes, including repaying the $150 million outstanding principal amount...
Analysis-Argentina meme coin scandal dents Milei's hunt for election allies
Analysis-Argentina meme coin scandal dents Milei's hunt for election allies
Feb 27, 2025
By Nicolás Misculin BUENOS AIRES (Reuters) - A meme coin scandal and investigation have dented the popularity of Argentina's libertarian President Javier Milei and hindered his efforts to strengthen political alliances ahead of congressional midterm elections this year. The brash former economist won a shock election in 2023 with pledges to take a chainsaw to public spending - and recently...
Nasdaq to Provide Cloud Infrastructure for Austria Financial Reporting System
Nasdaq to Provide Cloud Infrastructure for Austria Financial Reporting System
Feb 27, 2025
04:50 AM EST, 02/27/2025 (MT Newswires) -- Nasdaq (NDAQ) said Thursday it has made a deal with Austrian Reporting Services to provide regulatory reporting technology for Austria's financial services industry. Financial terms were not disclosed. Austrian Reporting Services is a collaboration of the country's major banks and financial services firms that is meant to consolidate regulatory reporting and send it...
Belite Bio Shares Phase 3 Interim Results for its Stargardt Disease Trial
Belite Bio Shares Phase 3 Interim Results for its Stargardt Disease Trial
Feb 27, 2025
04:47 AM EST, 02/27/2025 (MT Newswires) -- Belite Bio ( BLTE ) said Thursday that an independent data safety monitoring board has advised continuing the phase 3 Dragon trial of Tinlarebant for adolescent Stargardt disease without altering the study's structure. The recommendation to continue followed an interim analysis after all 104 participants completed a year of treatment and is expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved